NCT06258499View on ClinicalTrials.gov

Bone Healing Accelerant (BHA) Versus Autologous Bone Grafting (ABG) for Hindfoot or Ankle Arthrodesis

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

March 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

November 30, 2024

Conditions

Foot Deformities

Interventions

COMBINATION_PRODUCT

BHA

BHA active ingredients include a blood-derived component and beta-tricalcium phosphate. It is manually placed into the joint fusion space during fusion surgery.